Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Effat Un Nesa"'
Autor:
Huanmin Niu, Lilin Qian, Bin Sun, Wenjian Liu, Fang Wang, Qian Wang, Xiaotian Ji, Yanhai Luo, Effat Un Nesa, Hongxiang Lou, Huiqing Yuan
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 9, Iss 5, Pp 923-936 (2019)
It is critical to regulate the senescence-associated secretory phenotype (SASP) due to its effect on promoting malignant phenotypes and limiting the efficiency of cancer therapy. In this study, we demonstrated that marchantin M (Mar-M, a naturally oc
Externí odkaz:
https://doaj.org/article/80338043576e4a02951a3367a67a3331
Publikováno v:
Asian Pacific Journal of Tropical Medicine, Vol 11, Iss 13, Pp 24-24 (2018)
All over the world approximately 98 countries faces endemic outbreak of leishmaniases, which is a group of parasitic disease. More than 350 million people reside under the risk of these diseases and new cases per year is about 0.7 to 1.3 million. The
Externí odkaz:
https://doaj.org/article/6334ced230c348dca8b9d34a1b972cce
Autor:
Fengxia Xiao, Yufeng Cheng, Yuan Wang, Xuan Chen, Cong Wang, Effat Un Nesa, Xue Chen, Si Mi, Yan Qu, Shanghai Guan
Publikováno v:
Translational Cancer Research
Background The epigenetic alteration has an impact on cancer cell cycle regulation. Expression of histone deacetylase 8 (HDAC8) ruled out the expression of cyclin-dependent kinase inhibitor 2A (CDKN2A) and this is linked with the prognosis of Esophag
Autor:
Bin Sun, Huanmin Niu, Hong-Xiang Lou, Fang Wang, Huiqing Yuan, Qian Wang, Xiao-Tian Ji, Effat Un Nesa, Wenjian Liu, Lilin Qian, Yanhai Luo
Publikováno v:
Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 9, Iss 5, Pp 923-936 (2019)
Acta Pharmaceutica Sinica B, Vol 9, Iss 5, Pp 923-936 (2019)
It is critical to regulate the senescence-associated secretory phenotype (SASP) due to its effect on promoting malignant phenotypes and limiting the efficiency of cancer therapy. In this study, we demonstrated that marchantin M (Mar-M, a naturally oc
Autor:
Cong Wang, Tamanna Zahur, Ommega Internationals, Fengxia Xiao, Si Mi, Yan Qu, Yuan Wang, Xuan Chen, Effat Un Nesa, Yu Feng Cheng, Xue Chen, Shanghai Guan
Publikováno v:
International Journal of Cancer and Oncology. 6:19-25
Background: We determined to assess the HDAC8 expression in esophageal squamous cell carcinoma (ESCC) patients and prognostic potential though there is only a little research contribution regarding HDAC8 to tumorigenesis of ESCC. Methods: The immunoh
Autor:
Fang Wang, Yunqiu Wang, Liangyu Cai, Huanmin Niu, Deyu Zhu, Yanhai Luo, Xiaodan Wang, Mengqi Jia, Huiqing Yuan, Chuanjie Liang, Effat Un Nesa, Nan Sheng, Charles Y.F. Young, Jin Jiang
Publikováno v:
International Journal of Biological Sciences
Anterior gradient 2 (AGR2), a protein disulfide isomerase (PDI), is a well-established oncogene. Here, we found that Agr2-/- mice had a decreased fat mass and hepatic and serum lipid levels compared with their wild-type littermates after fasting, and
Autor:
Keli Tian, Effat Un Nesa, Shiqin Zhu, Qingqing Xu, Deyu Zhu, Huanmin Niu, Xuelei Hu, Huiqing Yuan, Xiulei Zhang, Xiaofei Liu
Publikováno v:
Journal of Cellular and Molecular Medicine
Therapeutic agents are urgently needed for treating metastatic castration‐refractory prostate cancer (mCRPC) that is unresponsive to androgen deprivation and chemotherapy. Our screening assays demonstrated that chemotherapy‐resistant prostate can
Autor:
Yufeng Cheng, Cong Wang, Pengxiang Chen, Yibin Jia, Yuan Liu, Yan Qu, Bo Cheng, Ziying Jiang, Effat Un Nesa, Jie Han
Publikováno v:
OncoTargets and therapy
Pengxiang Chen,1 Cong Wang,1 Bo Cheng,2 Effat Un Nesa,1 Yuan Liu,1 Yibin Jia,1 Yan Qu,1 Ziying Jiang,1 Jie Han,3 Yufeng Cheng1 1Department of Radiation Oncology, Qilu Hospital of Shandong University, Jinan, 2Medical College of Qingdao University, Qin
Autor:
Effat Un Nesa, Tamanna Khanam, Peng X. Chen, Cong Wang, Han Zhang, Li Jingyi, Muhammad Shahbaz, Xiao Y. Liu, Ying Sun, Yufeng Cheng, Muhammad Ijaz
Publikováno v:
Current Signal Transduction Therapy. 12:49-57
Autor:
Xue Chen, Yufeng Cheng, Effat Un Nesa, Yan Qu, Fengxia Xiao, Yuan Wang, Xuan Chen, Si Mi, Shanghai Guan, Cong Wang
Publikováno v:
Translational Cancer Research
The epigenetic alteration has an impact on cancer cell cycle regulation. Expression of histone deacetylase 8 (HDAC8) ruled out the expression of cyclin-dependent kinase inhibitor 2A (CDKN2A) and this is linked with the prognosis of Esophageal cancer